Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 12519X HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 2
MPNP 2768Q HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 3456X HALOPERIDOLhaloperidol 5 mg/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 2763K HALOPERIDOLhaloperidol 2 mg/mL oral liquid, 100 mL 1 1 5
MPNP 2767P HALOPERIDOLhaloperidol 1.5 mg tablet, 100 1 100 5
MPNP 2770T HALOPERIDOLhaloperidol 5 mg tablet, 50 1 50 5
MPNP 2761H HALOPERIDOLhaloperidol 500 microgram tablet, 100 1 100 5
MPNP 2766N HALOPERIDOL DECANOATEhaloperidol (as decanoate) 150 mg/3 mL injection, 5 x 3 mL ampoules 1 5 0
MPNP 2765M HALOPERIDOL DECANOATEhaloperidol (as decanoate) 50 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1466E HEPARINheparin sodium 5000 units/0.2 mL injection, 5 x 0.2 mL ampoules 1 5 5
MPNP 2652N HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio long chain fat to carbohydrate plus protein) powder for oral liquid, 300 g 24 24 5
MPNP 12456N HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNP 12789D HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNP 12464B HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 30 x 250 mL cartons 6 6 5
MPNP 10185C HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydrate plus protein) oral liquid, 32 x 200 mL cartons 5 5 5
MPNP 12635B HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate oral semi-solid, 36 x 100 g tubs 4 4 5
MPNP 9446E HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATEhigh fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydate plus protein) powder for oral liquid, 300 g 24 24 5
MPNP 2181T HYALURONATE SODIUMhyaluronate sodium 0.1% eye drops, 10 mL 1 1 5
MPNP 2253N HYALURONATE SODIUMhyaluronate sodium 0.2% eye drops, 10 mL 1 1 5
MPNP 13409R HYDROCHLOROTHIAZIDEhydrochlorothiazide 25 mg tablet, 100 2 200 1
MPNP 1484D HYDROCHLOROTHIAZIDEhydrochlorothiazide 25 mg tablet, 100 1 100 1
MPNP 1500Y HYDROCORTISONEhydrocortisone 20 mg tablet, 60 1 60 4
MPNP 13863P HYDROCORTISONEhydrocortisone 4 mg tablet, 50 2 100 4
MPNP 1499X HYDROCORTISONEhydrocortisone 4 mg tablet, 50 1 50 4
MPNP 2881P HYDROCORTISONE ACETATEhydrocortisone acetate 1% cream, 50 g 1 1 1
MPNP 2441L HYDROCORTISONE ACETATEhydrocortisone acetate 1% eye ointment, 5 g 1 1 0
MPNP 2882Q HYDROCORTISONE ACETATEhydrocortisone acetate 1% ointment, 50 g 1 1 1
MPNP 1502C HYDROCORTISONE ACETATEhydrocortisone acetate 10% enema, 21.1 g 2 2 3
MPNP 1501B HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 2 2 0
MPNP 1510L HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 6 6 0
MPNP 3470P HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 100 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 2 2 0
MPNP 1511M HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 6 6 0
MPNP 3096Y HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 1 1 0
MPNP 3471Q HYDROCORTISONE SODIUM SUCCINATEhydrocortisone (as sodium succinate) 250 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial 1 1 0
MPNP 12493M HYDROMORPHONEhydromorphone hydrochloride 2 mg/mL injection, 5 x 1 mL ampoules 2 10 1
MPNP 8420E HYDROMORPHONEhydromorphone hydrochloride 2 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 12565H HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 1
MPNP 12582F HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 0
MPNP 13796D HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 0
MPNP 13806P HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL 1 473 1
MPNP 12047C HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 0.5 10 0
MPNP 12497R HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 2 40 1
MPNP 8541M HYDROMORPHONEhydromorphone hydrochloride 2 mg tablet, 20 1 20 0
MPNP 12046B HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 0.5 10 0
MPNP 12484C HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 2 40 1
MPNP 8542N HYDROMORPHONEhydromorphone hydrochloride 4 mg tablet, 20 1 20 0
MPNP 12016K HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 0.5 10 0
MPNP 12515Q HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 2 40 1
MPNP 8543P HYDROMORPHONEhydromorphone hydrochloride 8 mg tablet, 20 1 20 0
MPNP 12531M HYDROMORPHONEhydromorphone hydrochloride 10 mg/mL injection, 5 x 1 mL ampoules 2 10 1
MPNP 8421F HYDROMORPHONEhydromorphone hydrochloride 10 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 14076W HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL 1 500 0
MPNP 14084G HYDROMORPHONEhydromorphone hydrochloride 1 mg/mL oral liquid, 500 mL 1 500 1
MPNP 2162T HYDROXOCOBALAMINhydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules 1 3 0
MPNP 9048F HYDROXOCOBALAMINhydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules 1 3 0
MPNP 1512N HYDROXYCHLOROQUINEhydroxychloroquine sulfate 200 mg tablet, 100 1 100 1
MPNP 9487H HYDROXYETHYL STARCH 130/0.4 + SODIUM CHLORIDEHYDROXYETHYL STARCH 130/0.4 I.V. infusion 30 g per 500 mL, 500 mL, 1 3 3 0
MPNP 3473T HYOSCINE BUTYLBROMIDEhyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 5317W HYOSCINE BUTYLBROMIDEhyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules 6 30 3
MPNP 11842G HYPROMELLOSEhypromellose 0.3% w/v eye drops, 10 mL 1 1 5
MPNP 2956N HYPROMELLOSEhypromellose 0.5% eye drops, 15 mL 1 1 5
MPNP 11625W HYPROMELLOSEhypromellose 0.3% w/w eye drops, 10 mL 1 1 5
MPNP 8564R HYPROMELLOSE + CARBOMER-980hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g 1 1 5